119 filings
Page 5 of 6
8-K
d7fh6b
17 Mar 20
Entry into a Material Definitive Agreement
4:52pm
8-K
4819dgix
12 Mar 20
X4 Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
7:36am
8-K
7x22fderz79
13 Feb 20
Departure of Directors or Certain Officers
4:18pm
8-K
xwj01k41o
10 Jan 20
Results of Operations and Financial Condition
4:00pm
8-K
1z8qenlmix xbowu
27 Nov 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class B Warrants
5:18pm
8-K
8mr9t0c
14 Nov 19
Entry into a Material Definitive Agreement
4:05pm
8-K
fkrc34j
7 Nov 19
X4 Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Business Highlights
7:10am
8-K/A
jddjyvw7
18 Oct 19
Departure of Directors or Certain Officers
4:31pm
8-K
prqi7ja69ycsi4u4whr
4 Oct 19
Regulation FD Disclosure
5:08pm
8-K
dhml 3uil
30 Sep 19
Subgroup exceeds target of 50% improvement in median progression-free survival
7:21am
8-K
6owukq7 w3ha
20 Sep 19
Departure of Directors or Certain Officers
4:16pm
8-K
q5ts69ti
9 Aug 19
Other Events
6:06am
8-K
d0geyzgz
28 Jun 19
Entry into a Material Definitive Agreement
8:30am
8-K
3c35o50j50bb4f 5pc
26 Jun 19
Other Events
8:44am
8-K
uu8qe1 c7oddj
19 Jun 19
Departure of Directors or Certain Officers
4:45pm
8-K/A
m6c 27iwoz8ie
17 May 19
Departure of Directors or Certain Officers
4:12pm
8-K/A
fmub37akj c4t9
13 May 19
Financial Statements and Exhibits
4:58pm
8-K
0o1fhq8n0u1 tn07mi
15 Apr 19
X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
4:41pm
8-K
clp05mhy apbo
12 Apr 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants
6:08am
8-K
egp94evl5yp9loogptj
11 Apr 19
Other Events
4:00pm